MEDIVIS S R L has a total of 42 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 1997. It filed its patents most often in Italy, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, environmental technology and basic materials chemistry are VAXFORM LLC, ODIDI ISA and INVEKRA S A P I DE C V.
# | Country | Total Patents | |
---|---|---|---|
#1 | Italy | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | United States | 4 | |
#5 | Australia | 2 | |
#6 | Canada | 2 | |
#7 | China | 2 | |
#8 | Mexico | 2 | |
#9 | Brazil | 1 | |
#10 | Chile | 1 | |
#11 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Basic materials chemistry | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Mangiafico Sergio | 36 |
#2 | Aleo Danilo | 35 |
#3 | Cro Melina | 27 |
#4 | Melilli Barbara | 20 |
#5 | Saita Maria Grazia | 18 |
#6 | Saita Maria Grazia Antonietta | 16 |
#7 | Spitaleri Fabiola | 3 |
#8 | Mangiafico Sebastiano | 2 |
#9 | Rolando Maurizio | 2 |
#10 | Sergio Mangiafico | 2 |
Publication | Filing date | Title |
---|---|---|
EP3701938A1 | Ophthalmic formulations based on atropine | |
IT201900002753A1 | Intraocular ophthalmic compositions for vitreo-retinal surgery | |
IT201900000561A1 | Chemically and physically stable topical ophthalmic formulations based on Nepafenac | |
ITUA20162425A1 | Ophthalmic composition comprising PVP-I | |
ITUB20154802A1 | OPHTHALMIC COMPOSITION | |
US2016074426A1 | Aqueous ophthalmic formulations based on azithromycin | |
WO2014174544A1 | Riboflavin formulations for trans-epithelial cross-linking | |
EP2579845A1 | Ophthalmic compositions for the administration of liposoluble acitve ingredients | |
WO2010106571A2 | Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids | |
EP2280689A1 | Stable ophthalmic formulations | |
WO2007125566A2 | Use of probiotics in the prevention and treatment of allergic conjunctivitis |